Monday July 16, 2018
Home India World Food In...

World Food India 2017: Netherlands to Participate as the ‘Focus Country’

To promote the grand event, Harsimrat Kaur Badal was in the Netherlands

0
//
44
world food india
World Food India 2017. Facebook
Republish
Reprint
  • The World Food India 2017 is to be organized in Delhi from the 3rd to 5th November
  • Netherlands has recently announced itself participating as the ‘focus country.’ 
  • India and Netherland have good bilateral ties, and this is another significant step forward

August 26, 2017: The World Food India 2017 will be organized from 3rd to 5th November in New Delhi. On Wednesday, Netherlands declared that it wishes to participate as a ‘focus country.’

Martijn van Dam, Netherlands’ Minister of Agriculture, expressed the decision of Netherlands to be the ‘Focus Country’ at the 2017 World Food India to the Minister of Food Processing Harsimran Kaur Badal.

Also Read: Dorset Indian Mela: Indian food festival on August 26 in the UK to Showcase different varieties of Cuisine and Culture

A business, as well as official delegation, will be sent by Netherlands for the event organized in the capital of India.

To promote the grand event, Harsimrat Kaur Badal was in the Hague, Netherlands.

The objective of the World Food India 2017 is to explain the policy environment of India to the global food industry. It further seeks to establish India as a major player in the global industry and provide investment platforms.

Netherlands, being the ‘focus country’ at the event, will get to showcase its expertise and knowledge about the food processing sector. This will include seminars through the country.

Harsimrat Kau badal speaking to ANI, stated, “World Food India welcomes The Netherlands as Focus Country and hopes that participation from The Netherlands will help businesses from both sides to leverage each other’s strengths for mutual benefit.” She also highlighted that good bilateral relationship exists between India and Netherlands and this is another step forward.

Netherlands has invested close to US $6 billion into India in the last couple of years. India is also doing good business with over 200 companies from Netherlands. However, there is still so much more potential of development.


NewsGram is a Chicago-based non-profit media organization. We depend upon support from our readers to maintain our objective reporting. Show your support by Donating to NewsGram. Donations to NewsGram are tax-exempt. 

Click here- www.newsgram.com/donate

Click here for reuse options!
Copyright 2017 NewsGram

Next Story

Cepheid to Establish Manufacturing Unit for TB Diagnostics in India

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment

0
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach. (IANS)

Expanding its footprint in India, US-based molecular diagnostics company Cepheid Inc on Thursday announced its plans to establish a manufacturing unit in the country to improve Tuberculosis (TB) diagnostics.

Cepheid’s GeneXpert MTB/RIF test is a closed-cartridge-based system that is easy to operate by minimally trained staff and gives results in approximately two hours, speeding the conventional backlog that used to exist in traditional diagnostic methods.

The new manufacturing unit would produce MTB/RIF test cartridges, contribute to the government’s “Make in India” initiative and thus bringing the company’s global expertise in TB diagnostics to India, the company said in a statement.

As part of the plan, Cepheid also unveiled its latest portable, easy-to-use TB-testing system — the GeneXpert Edge — which is expected to be available in India later this year, the company said.

The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.

“Cepheid recognises the need for technological advancement and is committed to contributing significantly to India’s goal of TB eradication,” said Peter Farrell, Executive Vice President, Worldwide Commercial Operations, Cepheid.

Cepheid's Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB)
Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB).

“We are hopeful that GeneXpert Edge will help eliminate delays in TB diagnostics by providing definitive results within hours and facilitating fast and easy last-mile delivery even in the remote villages of India,” he added.

India has nearly one-fourth of the global TB patients and an estimated 4.8 lakh lives are lost every year due to delayed diagnosis and inadequate treatment and there are above 2.5 million new cases of TB every year. The country aims to eradicate TB by 2025.

Approved by the World Health Organisation (WHO) in 2010, more than 1,200 Cepheid’s GeneXpert Systems have been installed in the last two years at various Revised National Tuberculosis Control Programme (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD).

Also Read: Fruit Bats Identified As Source Of Nipah Virus Outbreak in Kerala

Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB) and rifampicin-resistance mutations, which are markers for MDR-TB strains in under two hours.

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment.

Xpert MTB/RIF tests also have excellent negative predictive value, which allows clinicians to manage TB-negative patients more effectively to prevent unnecessary and costly respiratory isolations. (IANS)